Lv11
40 积分 2025-08-04 加入
Survival with Osimertinib plus Chemotherapy in EGFR -Mutated Advanced NSCLC
59分钟前
已完结
Survival with Osimertinib plus Chemotherapy in EGFR-Mutated Advanced NSCLC
1小时前
已关闭
Erlotinib Versus Etoposide/Cisplatin With Radiation Therapy in Unresectable Stage III Epidermal Growth Factor Receptor Mutation-Positive Non-Small Cell Lung Cancer: A Multicenter, Randomized, Open-Label, Phase 2 Trial
3个月前
已完结
皖公网安备34019202002308
